This Week in Nature

In this week's Nature Biotechnology, a team from Massachusetts General Hospital reports on the development of a next-generation CRISPR-based gene-editing platform. Monomeric Cas9 nucleases are commonly used to induce the genomic alterations in CRISPR systems, but the researchers note that these often result in unwanted off-target mutations.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

What You Eat

Be Gone

This Week in Cell

This Week in Nature

Beginning of the End?

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.